{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    9,
    10,
    11,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    37,
    38,
    39,
    40,
    41,
    42,
    43
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Empagliflozin",
        "type": {
          "id": "dbe2dad1-3a56-40e9-b363-96a1d7d012a8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "154849ff-ea8f-4fbb-9361-e8f9770b2365",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Orally available, potent, and selective inhibitor of the renal SGLT-2.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "3dc66546-0a5d-4333-88e4-983da47b76bc",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "4a8791ee-acb0-48e4-98f7-d535a6544cc6",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo film-coated tablets.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Guideline-directed medical therapy",
        "type": {
          "id": "0d863fda-16a8-4c41-ae9c-5b67933a2208",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "38f526fb-66f1-4cbe-9131-13d666c8e4a0",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard of care for Heart Failure including ACEi, ARB, β-blocker, oral diuretics, MRA, ARNI, and ivabradine."
      },
      {
        "id": "int_4",
        "name": "SGLT-2 inhibitors",
        "type": {
          "id": "84e694fe-8a09-4372-9fbc-1dd8086558ee",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9ccc4f0a-5a36-45a4-a31b-985e9b1c0485",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Use of any SGLT-2 inhibitors or combined SGLT-1 and 2 inhibitors (other than trial medication) is prohibited."
      },
      {
        "id": "int_5",
        "name": "Antidiabetic medications",
        "type": {
          "id": "e3f009ed-b247-412e-8913-a052070e76ef",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "b790e275-b994-4bda-8cb3-9f139fcbc13e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Adjusted individually as clinically indicated by the patient's care provider."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Jardiance",
        "administrableDoseForm": {
          "id": "d9102506-122f-44ce-9b30-14d0e1ee42bb",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "3b5cac71-3e5f-4d1a-9ad5-bfafd9a81bbe",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c660b828-624d-40ce-aa04-9d63ba8d514c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "10 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Boehringer Ingelheim"
      },
      {
        "id": "prod_2",
        "name": "Placebo matching empagliflozin",
        "administrableDoseForm": {
          "id": "b80216cc-c0ec-40d2-a3c6-1c65c831c84c",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "d1de54ce-e369-4576-88dc-bd128a76626a",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "a6d74216-d18e-4129-80da-babc3eacdeb6",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not applicable",
        "manufacturer": "Boehringer Ingelheim"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Empagliflozin 10 mg daily",
        "instanceType": "Administration",
        "dose": "10 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Approximately 20-38 months (event-driven trial)"
      },
      {
        "id": "admin_2",
        "name": "Placebo daily",
        "instanceType": "Administration",
        "dose": "1 tablet",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Approximately 20-38 months (event-driven trial)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Empagliflozin",
        "instanceType": "Substance",
        "description": "Active ingredient, also known as BI 10773."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Home monitoring device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      },
      {
        "id": "dev_2",
        "name": "Implantable Cardioverter Defibrillator (ICD)",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      },
      {
        "id": "dev_3",
        "name": "Cardiac Resynchronization Therapy (CRT)",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 5,
      "productCount": 2,
      "deviceCount": 3
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Empagliflozin",
        "role": "Investigational Product",
        "description": "Orally available, potent, and selective inhibitor of the renal SGLT-2."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo film-coated tablets."
      },
      {
        "name": "Guideline-directed medical therapy",
        "role": "Background Therapy",
        "description": "Standard of care for Heart Failure including ACEi, ARB, β-blocker, oral diuretics, MRA, ARNI, and ivabradine."
      },
      {
        "name": "SGLT-2 inhibitors",
        "role": "Concomitant Medication",
        "description": "Use of any SGLT-2 inhibitors or combined SGLT-1 and 2 inhibitors (other than trial medication) is prohibited."
      },
      {
        "name": "Antidiabetic medications",
        "role": "Concomitant Medication",
        "description": "Adjusted individually as clinically indicated by the patient's care provider."
      }
    ],
    "products": [
      {
        "name": "Jardiance",
        "doseForm": "Tablet",
        "strength": "10 mg",
        "manufacturer": "Boehringer Ingelheim"
      },
      {
        "name": "Placebo matching empagliflozin",
        "doseForm": "Tablet",
        "strength": "Not applicable",
        "manufacturer": "Boehringer Ingelheim"
      }
    ],
    "substances": [
      {
        "name": "Empagliflozin",
        "description": "Active ingredient, also known as BI 10773."
      }
    ],
    "administrations": [
      {
        "name": "Empagliflozin 10 mg daily",
        "dose": "10 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Approximately 20-38 months (event-driven trial)"
      },
      {
        "name": "Placebo daily",
        "dose": "1 tablet",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "Approximately 20-38 months (event-driven trial)"
      }
    ],
    "devices": [
      {
        "name": "Home monitoring device",
        "manufacturer": "Not specified",
        "purpose": "To measure blood ketones in patients with T1DM"
      },
      {
        "name": "Implantable Cardioverter Defibrillator (ICD)",
        "manufacturer": "Not specified",
        "purpose": "Device therapy for heart failure consistent with CV guidelines"
      },
      {
        "name": "Cardiac Resynchronization Therapy (CRT)",
        "manufacturer": "Not specified",
        "purpose": "Device therapy for heart failure consistent with CV guidelines"
      }
    ]
  }
}